# Comparing Rapid Micro-Induction and Standard Induction of Buprenorphine/Naloxone for Treatment of Opioid Use Disorder

> **NCT04234191** · PHASE2 · RECRUITING · sponsor: **University of British Columbia** · enrollment: 50 (estimated)

## Conditions studied

- Opioid Use Disorder

## Interventions

- **DRUG:** Buprenorphine/naloxone
- **DRUG:** Hydromorphone

## Key facts

- **NCT ID:** NCT04234191
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-08-18
- **Primary completion:** 2025-01
- **Final completion:** 2025-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04234191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04234191, "Comparing Rapid Micro-Induction and Standard Induction of Buprenorphine/Naloxone for Treatment of Opioid Use Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04234191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*